{
    "Regions": {
        "1": "Africa",
        "2": "Americas",
        "3": "South-East Asia",
        "4": "Europe",
        "5": "Eastern Mediterranean",
        "6": "Western Pacific",
        "7": "Unspecified",
        "8": "Not known"
    },
    "Subregions": {
        "1": "China",
        "2": "Established Market Economies",
        "3": "Formerly Socialist Economies of Europe",
        "4": "India",
        "5": "Latin America and the Caribbean",
        "6": "Middle East Crescent",
        "7": "Other Asia and Islands",
        "8": "Sub-Saharan Africa",
        "9": "Global",
        "10": "Eastern Asia",
        "11": "Southern Asia",
        "12": "Low- and middle- income countries of the African Region",
        "13": "Low- and middle- income countries of the Americas",
        "14": "Low- and middle- income countries of the Eastern Mediterranean Region",
        "15": "Low- and middle- income countries of the European Region",
        "16": "Low- and middle- income countries of the South-east Asia Region",
        "17": "World",
        "18": "Low- and middle- income countries of the Western Pacific Region",
        "19": "High-income countries",
        "20": "Asia Pacific, High-income",
        "21": "Asia, Central",
        "22": "Asia, East",
        "23": "Asia, South",
        "24": "Asia, Southeast",
        "25": "Australasia",
        "26": "Caribbean",
        "27": "Europe, Central",
        "28": "Europe, Eastern",
        "29": "Europe, Western",
        "30": "Latin America, Andean",
        "31": "Latin America, Central",
        "32": "Latin America, Southern",
        "33": "Latin America, Tropical",
        "34": "North Africa/Middle East",
        "35": "North America, High-income",
        "36": "Oceania",
        "37": "Sub-Saharan Africa, Central",
        "38": "Sub-Saharan Africa, East",
        "39": "Sub-Saharan Africa, Southern",
        "40": "Sub-Saharan Africa, West",
        "41": "Unspecified",
        "42": "Not known"
    },
    "StudySubject": {
        "1": "Humans",
        "2": "Animals",
        "3": "Invertebrates",
        "4": "Bacteria",
        "5": "Viruses",
        "6": "Organism Forms, Other",
        "7": "Unspecified",
        "8": "Not applicable",
        "9": "Not known"
    },
    "Ethnicity": {
        "1": "Asian",
        "2": "Black",
        "3": "White",
        "4": "Mixed",
        "5": "Other",
        "6": "Unspecified",
        "7": "Not known"
    },
    "AgeGroups": {
        "1": "Adolescent",
        "2": "Adult ",
        "3": "Aged ",
        "4": "Frail Elderly",
        "5": "Child",
        "6": "Infant",
        "7": "Newborn",
        "8": "Other",
        "9": "Unspecified",
        "10": "Not applicable",
        "11": "Not known"
    },
    "Rurality": {
        "1": "Rural Population",
        "2": "Suburban Population",
        "3": "Urban Population",
        "4": "Unspecified",
        "5": "Not applicable",
        "6": "Not known"
    },
    "VulnerablePopulations": {
        "1": "Disabled persons",
        "2": "Drug users",
        "3": "Refugees",
        "4": "Indigenous People",
        "5": "Sexual and gender minorities ",
        "6": "Prisoners",
        "7": "Sex workers",
        "8": "Smokers",
        "9": "Women",
        "10": "Pregnant women",
        "11": "Minority communities unspecified",
        "12": "Vulnerable populations unspecified",
        "13": "Unspecified",
        "14": "Not applicable",
        "15": "Not known"
    },
    "OccupationalGroups": {
        "1": "Farmers",
        "2": "Emergency Responders",
        "3": "Military Personnel",
        "4": "Social Workers",
        "5": "Caregivers",
        "6": "Health Personnel",
        "7": "Hospital personnel ",
        "8": "Nurses and Nursing Staff",
        "9": "Physicians",
        "10": "Dentists and dental staff ",
        "11": "Veterinarians",
        "12": "Volunteers",
        "13": "Unspecified",
        "14": "Not applicable",
        "15": "Not known"
    },
    "StudyType": {
        "1": "Case Reports",
        "2": "Clinical Conference",
        "3": "Clinical Study",
        "4": "Comparative Study",
        "5": "Consensus Development Conference",
        "6": "Evaluation Study",
        "7": "Meta-Analysis",
        "8": "Multicenter Study",
        "9": "Scientific Integrity Review",
        "10": "Systematic Review",
        "12": "Validation Study",
        "13": "Observational Study",
        "14": "Biological Specimen Banks",
        "15": "Policy report",
        "16": "Study, design unspecified",
        "17": "Unspecified",
        "18": "Not applicable",
        "19": "Not known"
    },
    "ClinTrial": {
        "1": "Adaptive Clinical Trial",
        "2": "Clinical Trial, Phase I ",
        "3": "Clinical Trial, Phase II",
        "4": "Clinical Trial, Phase III",
        "5": "Clinical Trial, Phase IV",
        "6": "Controlled Clinical Trial",
        "7": "Randomized Controlled Trial",
        "8": "Clinical Trial Protocol",
        "9": "Clinical Trial, Veterinary",
        "10": "Randomized Controlled Trial, Veterinary",
        "11": "Unspecified",
        "12": "Not applicable",
        "13": "Not known"
    },
    "WHOGHObservatoryFramework": {
        "1": "Cause",
        "2": "Solution",
        "3": "Drug Development",
        "4": "Diagnostics/Screening",
        "5": "Device",
        "6": "Vaccine",
        "7": "Vector Control",
        "8": "Basic Science",
        "9": "Unspecified",
        "10": "Implementation",
        "11": "Evaluation",
        "12": "No research category assigned",
        "13": "Unspecified",
        "14": "Not applicable",
        "15": "Not known"
    },
    "Diseases": {
        "840539006": "COVID-19",
        "43489008": "Crimean-Congo haemorrhagic fever",
        "37109004": "Ebola virus disease",
        "7503002": "Marburg virus disease",
        "19065005": "Lassa fever",
        "651000146102": "Middle East Respiratory Syndrome Coronavirus (MERS-CoV)",
        " 398447004": "Severe Acute Respiratory Syndrome (SARS)",
        "406597005": "Nipah and henipaviral disease",
        "402917003": "Rift Valley Fever",
        "3928002": "Zika",
        "1": "Unspecified",
        "2": "Not applicable",
        "3": "Not known"
    },
    "Pathogens": {
        "1263733001": "SARS-CoV",
        "1263732006": "SARSr-CoV",
        "840533007": "SARS-CoV-2",
        "43489008": "Crimean-Congo haemorrhagic fever virus",
        "243621001": "Genus Nairoviruses",
        "243615000": "Family Bunyaviridae",
        "424206003": "Ebola Virus",
        " 424206003": "Genus Ebolavirus",
        "407325004": "Family Filoviridae",
        "424421007": "Genus Marburgvirus",
        "85944001": "Lassa fever virus",
        "58234003": "Genus Arenavirus",
        "243624009": "Family Arenaviridae",
        "697932005": "Middle East Respiratory Syndrome Coronavirus (MERS-CoV)",
        "868192004": "Subgenus Merbecovirus",
        "84101006": "Human coronavirus",
        "115511007": "Nipah virus",
        "407486001": "Genus Henipavirus",
        "28335002": "Rift Valley Fever virus",
        "82945006": "Genus Phlebovirus",
        "50471002": "Zika virus",
        "28375005": "Flavivirus Genus",
        "243602009": "Family Flaviviridae (including Dengue)",
        "449024000": "Pandemic influenza A (H1N1)",
        "1": "Unspecified",
        "2": "Not applicable",
        "3": "Not known"
    },
    "ResearchCat": {
        "1": "Pathogen: natural history, transmission and diagnostics",
        "2": "Animal and environmental research and research on diseases vectors ",
        "3": "Epidemiological studies",
        "4": "Clinical characterisation and management  in humans                             ",
        "5": "Infection prevention and control  (including health care workers' protection)",
        "6": "Therapeutics research, development and implementation",
        "7": "Vaccines research, development and implementation",
        "8": "Research to inform ethical issues",
        "9": "Public health and Policy",
        "10": "Indirect and Secondary impacts of disease",
        "11": "Health Systems Research ",
        "12": "Capacity Strengthening",
        "13": "Disease Surveillance",
        "14": "Other"
    },
    "ResearchSubcat": {
        "1": {
            "1": "Diagnostics",
            "2": "Pathogen morphology, shedding & natural history",
            "3": "Pathogen genotyping, mutations and adaptations",
            "4": "Immunity",
            "5": "Disease models",
            "6": "Environmental stability of pathogen",
            "7": "Other"
        },
        "2": {
            "8": "Animal source and routes of transmission",
            "9": "Vector biology ",
            "10": "Vector control strategies",
            "11": "Other"
        },
        "3": {
            "12": "Disease transmission",
            "13": "Disease susceptibility",
            "14": "Impact/ effectiveness of control measures ",
            "15": "Disease mapping ",
            "16": "Other"
        },
        "4": {
            "17": "Prognostic factors for disease severity",
            "18": "Disease pathogenesis",
            "19": "Supportive care, processes of care and management ",
            "20": "Post acute and long term health consequences",
            "21": "Other"
        },
        "5": {
            "22": "Restriction measures to prevent secondary transmission in communities",
            "23": "Barriers,  PPE, environmental, animal and vector control measures",
            "24": "IPC in health care settings",
            "25": "IPC at the human-animal interface ",
            "26": "Other"
        },
        "6": {
            "27": "Pre-clinical studies",
            "28": "Phase 0 clinical trial",
            "29": "Phase 1 clinical trial",
            "30": "Phase 2 clinical trial",
            "31": "Phase 3 clinical trial",
            "32": "Phase 4 clinical trial",
            "33": "Prophylactic use of treatments",
            "34": "Therapeutics logistics and supply chains and distribution strategies",
            "35": " Therapeutic trial design",
            "36": "Adverse events associated with therapeutic administration",
            "37": "Other"
        },
        "7": {
            "38": "Pre-clinical studies",
            "39": "Phase 0 clinical trial",
            "40": "Phase 1 clinical trial",
            "41": "Phase 2 clinical trial",
            "42": "Phase 3 clinical trial",
            "43": "Phase 4 clinical trial",
            "44": "Vaccine logistics and supply chains and distribution strategies",
            "45": "Vaccine design and administration",
            "46": "Vaccine trial design and infrastructure",
            "47": "Adverse events associated with  immunization",
            "48": "Characterisation of vaccine-induced immunity",
            "49": "Other"
        },
        "8": {
            "50": "Research to inform ethical issues in Research ",
            "51": "Research to inform ethical issues related to Public Health Measures",
            "52": "Research to inform ethical issues in Clinical and Health System Decision-Making",
            "53": "Research to inform ethical issues in the Allocation of Resources ",
            "54": "Research to inform ethical issues in Governance ",
            "55": "Research to inform ethical issues related to Social Determinants of Health, Trust, and Inequities",
            "56": "Other"
        },
        "9": {
            "57": "Approaches to public health interventions ",
            "58": "Community engagement",
            "59": "Communication and infodemic management",
            "60": "Vaccine/Therapeutic/ treatment hesitancy",
            "61": "Policy research and interventions",
            "62": "Other"
        },
        "10": {
            "63": "Indirect health impacts",
            "64": "Impacts on social services",
            "65": "Economic impacts",
            "66": "Other secondary impacts ",
            "67": "Other "
        },
        "11": {
            "68": "Health service delivery  ",
            "69": "Health financing",
            "70": "Medicines, vaccines & other technologies ",
            "71": "Health information systems",
            "72": "Health leadership and governance",
            "73": "Health workforce",
            "74": "Other"
        },
        "12": {
            "75": "Individual level capacity strengthening ",
            "76": "Institutional level capacity strengthening ",
            "77": "Systemic/environmental components of capacity strengthening",
            "78": "Cross-cutting ",
            "79": "Other"
        },
        "13": {
            "80": "Disease surveillance detection",
            "81": "Disease surveillance verification",
            "82": "Disease surveillance notification",
            "83": "Disease surveillance response ",
            "84": "Disease surveillance integration",
            "85": "Analysis for disease surveillance",
            "86": "Disease surveillance reporting",
            "87": "Decisions related to  disease surveillance",
            "88": "Disease surveillance evaluation",
            "89": "Disease surveillance governance ",
            "90": "Other"
        }
    }
}
